Correction to: Nature https://doi.org/10.1038/nature04681 Published online 4 May 2006
In the Letter “Downstream nuclear events in brassinosteroid signalling”, the following mistakes were made during figure mounting.
The published Fig. 3a depicts a western blot experiment monitoring the phosphorylation status and levels of BES1 at different time points (1, 2, 4 hours) after treatment with brassinolide (BL) or mock. Figure 3a contains undisclosed cropping to organize samples differently from the original experiment and to show a single untreated control, as no change in BES1 phosphorylation or levels was observed with time in mock-treated plants. In addition, an inversion of lanes between the 2 h and 4 h +BL signals occurred during figure preparation. We have retrieved the original blot (shown in the Supplementary Information) and have produced a corrected panel for Fig. 3a in which cropped regions are shown with dotted lines (Corrected Fig. 3a). The correction does not alter the original conclusions that BL treatment leads to dephosphorylation of the BES1 transcription factor, with little or no change in total BES1 levels in our conditions.
The published Fig. 3b shows a western blot experiment for BES1 in different genetic backgrounds following mock or BL treatments, as well as exposure of wild-type (WT) plants to the BL biosynthetic inhibitor brassinazole (BRZ) to deplete endogenous BRs. The original blot was modified to remove background shadows above P-BES1 signals without mention in the corresponding legend. We have recovered the original blot (shown in the Supplementary Information), and have produced a new panel supporting the prominent role of BL in controlling BES1 phosphorylation status, with no obvious change in the accumulation of BES1 protein in our conditions (Corrected Fig. 3b below). Additionally, the signal corresponding to WT plants grown on BRZ results from the duplication of the BL-deficient det2-1 background lane. The fact that BES1 accumulates under its P-BES1 form in absence of BL and that BL addition promotes the dephosphorylation of P-BES1 into BES1 had already been observed in several independent studies1,2,3, and by us in other unpublished experiments showing the effect of BL and BRZ now shown below (Unpublished Fig. 1). The western blot shown on the corrected Fig. 3b therefore lacks the WT+BRZ lane and, consistently, the phenotype of a BRZ-grown plant was removed. We apologize for such alteration of the blot. The conclusions of this experiment remain unchanged.
There are several additional duplications:
-
1.
Duplications of Ubq10 RT-PCR DNA loading control gels between Supplementary Fig. S1b and Fig. S5 (lanes 1, 2), and between Supplementary Fig. S3c and Fig. S5 (lanes 1, 2; lanes 4, 5, respectively).
-
2.
Possible duplications of lanes 1, 2 between the two subpanels of Supplementary Fig. S3c.
-
3.
Duplications in Supplementary Fig. S5: lanes 3 and 4, BIN2-GFP; and lanes 4 and 5, actin.
Careful examination of other RT-PCR DNA gels highlighted some similarities for Ubq10 between the two panels of Supplementary Fig. S2b.
The seeds corresponding to most lines failed to germinate, except for bin2-3, for which we were able to repeat the experiment presented in the published Supplementary Fig. S1b (full DNA gels are found in the Supplementary Information of this correction file). We therefore built a new panel and confirmed our original conclusions that the bin2-3 allele is a knock-out mutant for the BIN2 gene, and that BIN2 acts as a negative regulator of brassinosteroid signalling (Corrected Supplementary Fig. S1b). In contrast to WT plants, no amplification of BIN2 was indeed observed using cDNAs from bin2-3 while the ACT2 loading control was amplified in both backgrounds. The ACT2 primers used are 5′-GCCCAGAAGTCTTGTTCCAG-3′ and 5′-TCATACTCGGCCTTGGAGAT-3′.
The published Supplementary Fig. S5 depicts the accumulation of BIN2-GFP or bin2-GFP (carrying the E263K gain-of-function mutation) proteins and corresponding mRNA, to confirm that the transgenic lines used expressed transgenes to comparable levels. The protein blot probed with GFP antibodies, aiming at detecting both BIN2-GFP and bin2-GFP, was cropped to remove a lane corresponding to a BIN2-GFP transgenic line that failed to accumulate the corresponding protein and that in addition had a severe phenotype unrelated to brassinosteroids. A similar cropping was performed on the corresponding BIN2-GFP RT-PCR DNA gel. We apologize for not having clearly described such croppings in the corresponding legend. We found the original BIN2-GFP protein blot and BIN2-GFP DNA gel (shown in the Supplementary Information) and have highlighted cropped regions with dotted lines. The published Ubq10 DNA corresponded to a different replicate experiment and has therefore been replaced by the appropriate one in the corrected Supplementary Fig. S5. Additionally, when building the published figure, lane 3 (BIN2::bin2-GFP#1) from the BIN2-GFP protein blots was accidentally used for lanes 4 and 5 (BIN2::BIN2-GFP#4 and #7) as well as lane 4 from the actin blot duplicated as lane 5. The actin loading control blot could not be recovered. We have therefore built a corrected figure panel below, using a non-specific band as loading control (Corrected Supplementary Fig. S5).
The authors apologize deeply for the inconvenience caused. The abovementioned corrections do not change the main conclusions of the published article. In addition, the findings reported in our original article regarding the role of BIN2 and related GSK3 kinases in brassinosteroid signalling, as well as the role of BIN2 phosphorylation in regulating DNA-binding of BES1-related transcription factors, have been fully validated by independent groups4,5.
References
Yin, Y. et al. BES1 accumulates in the nucleus in response to brassinosteroids to regulate gene expression and promote stem elongation. Cell 109, 181–191 (2002).
Wang, Z. Y. et al. Nuclear-localized BZR1 mediates brassinosteroid-induced growth and feedback suppression of brassinosteroid biosynthesis. Dev. Cell 2, 505–513 (2002).
He, J. X., Gendron, J. M., Yang, Y., Li, J. & Wang, Z. Y. The GSK3-like kinase BIN2 phosphorylates and destabilizes BZR1, a positive regulator of the brassinosteroid signaling pathway in Arabidopsis. Proc. Natl Acad. Sci. USA 99, 10185–10190 (2002).
Gampala, S. S. et al. An essential role for 14-3-3 proteins in brassinosteroid signal transduction in Arabidopsis. Dev. Cell 13, 177–189 (2007).
Yan, Z., Zhao, J., Peng, P., Chihara, R. K. & Li, J. BIN2 functions redundantly with other Arabidopsis GSK3-like kinases to regulate brassinosteroid signaling. Plant Physiol. 150, 710–721 (2009).
Friedrichsen, D. M., Joazeiro, C. A., Li, J., Hunter, T. & Chory, J. Brassinosteroid-insensitive-1 is a ubiquitously expressed leucine-rich repeat receptor serine/threonine kinase. Plant Physiol. 123, 1247–1256 (2000).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information is available in the online version of this amendment.
Supplementary information
Source data Fig. 3a,b and Supplementary Figs. S1b, S5.
Full blots and gels.
Rights and permissions
About this article
Cite this article
Vert, G., Chory, J. Author Correction: Downstream nuclear events in brassinosteroid signaling. Nature 625, E8–E10 (2024). https://doi.org/10.1038/s41586-023-06766-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-023-06766-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.